These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 37476314)

  • 1. Tremor in Patients with Relapsing-Remitting Multiple Sclerosis: Clinical Characteristics and Impact on Quality of Life.
    Shalash A; Elhodeby AM; Saad M; Abdelzaher Ibrahim Y; Hamid E; Nasef A
    Mov Disord Clin Pract; 2023 Jul; 10(7):1099-1106. PubMed ID: 37476314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis.
    Schuldesz AC; Maganti RK; Tudor R; Cornea A; Prodan M; Toma AO; Fericean RM; Simu M
    Diseases; 2024 Jun; 12(6):. PubMed ID: 38920559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLEEP DISORDERS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS.
    Odintsova TA; Kopchak OO
    Wiad Lek; 2021; 74(2):257-262. PubMed ID: 33813482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar Contributions to Motor and Cognitive Control in Multiple Sclerosis
    Fritz NE; Edwards EM; Ye C; Prince J; Yang Z; Gressett T; Keller J; Myers E; Calabresi PA; Zackowski KM
    Arch Phys Med Rehabil; 2022 Aug; 103(8):1592-1599. PubMed ID: 34998712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tremor in Multiple Sclerosis-An Overview and Future Perspectives.
    Makhoul K; Ahdab R; Riachi N; Chalah MA; Ayache SS
    Brain Sci; 2020 Oct; 10(10):. PubMed ID: 33053877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations.
    Kalb R; Feinstein A; Rohrig A; Sankary L; Willis A
    Curr Neurol Neurosci Rep; 2019 Aug; 19(10):77. PubMed ID: 31463644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis.
    Boonstra FM; Noffs G; Perera T; Jokubaitis VG; Vogel AP; Moffat BA; Butzkueven H; Evans A; van der Walt A; Kolbe SC
    Mult Scler; 2020 May; 26(6):696-705. PubMed ID: 30907236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Movement disorders in early MS and related diseases: A prospective observational study.
    Abboud H; Yu XX; Knusel K; Fernandez HH; Cohen JA
    Neurol Clin Pract; 2019 Feb; 9(1):24-31. PubMed ID: 30859004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis.
    Filippi M; Bar-Or A; Piehl F; Preziosa P; Solari A; Vukusic S; Rocca MA
    Nat Rev Dis Primers; 2018 Nov; 4(1):43. PubMed ID: 30410033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability.
    Candeias da Silva C; Bichuetti DB; Azevedo Silva SMC; Ferraz HB; Oliveira EML; Borges V
    Parkinsonism Relat Disord; 2018 Jun; 51():73-78. PubMed ID: 29530725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroscience research in Africa: Current status.
    Abd-Allah F; Kissani N; William A; Oraby MI; Moustafa RR; Shaker E; El-Tamawy MS; Shakir R
    eNeurologicalSci; 2016 Jun; 3():7-10. PubMed ID: 29430528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
    Thompson AJ; Banwell BL; Barkhof F; Carroll WM; Coetzee T; Comi G; Correale J; Fazekas F; Filippi M; Freedman MS; Fujihara K; Galetta SL; Hartung HP; Kappos L; Lublin FD; Marrie RA; Miller AE; Miller DH; Montalban X; Mowry EM; Sorensen PS; Tintoré M; Traboulsee AL; Trojano M; Uitdehaag BMJ; Vukusic S; Waubant E; Weinshenker BG; Reingold SC; Cohen JA
    Lancet Neurol; 2018 Feb; 17(2):162-173. PubMed ID: 29275977
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.